Beximco Pharmaceuticals Limited

Beximco Pharmaceuticals Limitedverified

BXP.L

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2005-10-21

Stock Exchange

LSE

Ticker

BXP.L

The Enterprise Value as of December 2025 (TTM) for Beximco Pharmaceuticals Limited (BXP.L) is 35.80B

According to Beximco Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 35.80B. This represents a change of 34.49% compared to the average of 26.62B of the last 4 quarters.

Beximco Pharmaceuticals Limited (BXP.L) Historical Enterprise Value (quarterly & annually)

How has BXP.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Beximco Pharmaceuticals Limited over the last ten years is 30.79B. The current 35.80B Enterprise Value has changed 11.53% with respect to the historical average. Over the past ten years (40 quarters), BXP.L's Enterprise Value was at its highest in in the December 2021 quarter at 72.10B. The Enterprise Value was at its lowest in in the March 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

30.79B

Median

30.57B

Minimum

12.53B

Maximum

51.98B

Beximco Pharmaceuticals Limited (BXP.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Beximco Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 107.74%

Maximum Annual Enterprise Value = 51.98B

Minimum Annual Increase = -33.42%

Minimum Annual Enterprise Value = 12.53B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202431.04B-0.83%
202331.30B-33.42%
202247.02B-9.54%
202151.98B107.74%
202025.02B-14.74%
201929.35B-12.82%
201833.66B11.83%
201730.10B89.39%
201515.89B26.84%
201412.53B22.18%

Beximco Pharmaceuticals Limited (BXP.L) Average Enterprise Value

How has BXP.L Enterprise Value performed in the past?

The current Enterprise Value of Beximco Pharmaceuticals Limited (BXP.L) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

36.46B

5-year avg

37.27B

10-year avg

30.79B

Beximco Pharmaceuticals Limited (BXP.L) Enterprise Value vs. Peers

How is BXP.L’s Enterprise Value compared to its peers?

Beximco Pharmaceuticals Limited’s Enterprise Value is greater than Faron Pharmaceuticals Oy (235.38M), greater than Animalcare Group plc (182.20M), greater than Optima Health plc (180.00M), greater than Tristel PLC (164.66M), greater than Shield Therapeutics plc (130.91M), greater than Diaceutics PLC (112.32M), greater than Venture Life Group plc (99.97M), greater than Bioventix PLC (90.11M), greater than ECO Animal Health Group plc (52.68M), greater than EKF Diagnostics Holdings plc (91.39M),

Build a custom stock screener for Beximco Pharmaceuticals Limited (BXP.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beximco Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Beximco Pharmaceuticals Limited (BXP.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Beximco Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Beximco Pharmaceuticals Limited's Enterprise Value?

What is the highest Enterprise Value for Beximco Pharmaceuticals Limited (BXP.L)?

What is the 3-year average Enterprise Value for Beximco Pharmaceuticals Limited (BXP.L)?

What is the 5-year average Enterprise Value for Beximco Pharmaceuticals Limited (BXP.L)?

How does the current Enterprise Value for Beximco Pharmaceuticals Limited (BXP.L) compare to its historical average?